Innovative Drug Development in China
March 27, 2025
40 Minutes
Join the Webinar as per Your Time Zone
For Americas & European Region
11:00 AM EDT | 10:00 AM CDT | 8:00 AM PDT | 4:00 PM GMT
For Rest of the World
11:30 AM IST
What is it all about?
China is rapidly emerging as a global hub for pharmaceutical innovation, with its market projected to reach $125 billion by 2025. Regulatory reforms, increased R&D investments, and government initiatives like Healthy China 2030 have created significant opportunities for innovative drug development. However, navigating China’s complex Regulatory landscape, fast-track approval pathways, and clinical study requirements remains a challenge.
Are you looking to expand into China’s pharmaceutical market or streamline Regulatory approvals? Join our webinar to gain expert insights and practical guidance for successful drug development in China.
The webinar will be hosted by Shruti Dwivedi and will be presented by Jane Zhang.
This session will give you practical insights into China’s evolving pharmaceutical market, helping you tackle regulatory challenges with confidence and streamline your drug development journey.
Key Topics to Be Covered:
- Understanding China’s drug approval system, accelerated review pathways, and Regulatory communication strategies.
- Exploring key strategies for drug development, clinical studies, and marketing authorization.
- Identifying common hurdles, industry benefits, and expert recommendations for successful drug development in China.
We respect your busy schedule and truly appreciate your time. We look forward to welcoming you to this insightful session! Reserve your spot today.
Shruti Dwivedi is an emerging Strategic Pharmaceutical Marketer with experience in International B2B Marketing Management. As the Team Lead for Marketing Strategy,she supports Regulatory Marketing Initiatives across the Asia Pacific and Latin America regions by contributing to Brand Management and Global Marketing Campaigns.
Jane Zhang has over seventeen (17+) years of experience in new drug R&D and more than twenty (20+) years of experience in Regulatory Affairs (RA). She possesses a deep understanding of NMPA and global regulations, including FDA, EU, and ICH. Her strong scientific background, extensive knowledge, and previous role as a CDE reviewer contribute to her comprehensive understanding and interpretation of these regulations.
Host
Shruti Dwivedi
Team Lead, MPR Marketing Strategy
Presenter
Jane Zhang
Sr. Director Regulatory Affairs, Freyr China